EUVIMEDScopri EUVIMED
BeobachtungsstudieOpen access · CC BY-NC 3.0

Characterizing ECOPD Phenotypes: Associations with In-Hospital Outcomes and Immunoinflammatory Mechanisms

Qin Wang, Lei Wang, Li Zhang, Chongyang Zhao, Ying Liu, Lei Liu, Lishan Yuan, Min Feng, Gang Wang, Li Li, Shuwen Zhang, Yulai Yuan and 2 more

International Journal of Chronic Obstructive Pulmonary Disease · 2025

DOI: 10.2147/copd.s505016 ↗

At a glance

Beobachtungsstudie in International Journal of Chronic Obstructive Pulmonary Disease, 2025. Written by Qin Wang and 13 co-authors. Institution: Department of Evidence-Based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive. 54 references. The full text is freely available (open access, CC BY-NC 3.0). Funded by: 1.3.5 project for disciplines of excellence-Clinical Research Fund, West China Hospital, Sichuan University, Science and Technology Foundation of Sichuan Province.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Hospitalization due to exacerbations of chronic obstructive pulmonary disease (ECOPD) is linked to substantial mortality rates.

Objective

This study aimed to identify the clinical and inflammatory phenotypes of patients with ECOPD, as well as to examine their associations with in-hospital outcomes. We sought to explore the underlying mechanisms that contribute to the relationship between ECOPD phenotypes and these outcomes.

Methods

A k-means cluster analysis was conducted on 20,890 recruited patients hospitalized for ECOPD. Logistic regression analyses were utilized to evaluate the associations between the identified phenotypes and in-hospital outcomes, such as mortality, invasive mechanical ventilation (IMV), and intensive care unit (ICU) admission. Additionally, a mediation analysis was performed to elucidate the immunoinflammatory mechanisms underlying the relationship between ECOPD phenotypes and in-hospital outcomes.

Results

Three distinct phenotypes were identified: Cluster 1 (n=4,944, 23.67%) exhibited a "Female Eosinophilic Phenotype", Cluster 2 (n=10,814, 51.77%) displayed a "Male Eosinophilic Phenotype", and Cluster 3 (n=5,132, 24.57%) presented as an "Geriatric Multimorbidity-Associated Neutrophilic Systemic Inflammatory Phenotype". Clusters 2 and 3 were associated with higher risks of in-hospital mortality (adjusted odds ratio [ORadj]=1.88 and 17.07, respectively) and IMV (ORadj=2.52 and 7.59, respectively) compared to Cluster 1. Patients in Cluster 3 also experienced an extended hospital stay (median of 13 days) and an increased risk of ICU admission (ORadj=7.72). Additionally, blood eosinophils, neutrophils, CRP, and albumin played a mediating role in the relationship between ECOPD phenotypes and the composite outcome.

Conclusion

Our study identified three phenotypes stratified by sex, multimorbidity burden, and inflammatory endotypes, which advanced threshold definition for eosinophilic exacerbations and provided prognostic insights for ECOPD management.

Subjects

MeSH terms (MEDLINE)

Pulmonary Disease, Chronic ObstructiveHumansMaleFemalePhenotypeAgedHospital MortalityMiddle AgedRisk FactorsDisease ProgressionAged, 80 and overIntensive Care UnitsNeutrophilsRespiration, ArtificialRisk AssessmentPrognosisEosinophilsSex FactorsHospitalizationTime FactorsCluster Analysis

Author keywords

ECOPDcluster analysisendotypeexacerbations of chronic obstructive pulmonary diseaseimmunoinflammationin-hospital outcomephenotype

Authors and institutions

  • Department of Evidence-Based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia.
  • Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, Sydney, Australia.
  • Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  • Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China.

ORCID profiles: Deying Kang, Xin Zhang

Funding

  • 1.3.5 project for disciplines of excellence-Clinical Research Fund
  • West China Hospital, Sichuan University
  • Science and Technology Foundation of Sichuan Province
  • National Natural Science Foundation of China
  • Post-Doctor Research Project, West China Hospital, Sichuan University
  • China Postdoctoral Science Foundation
  • National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University

Cite

APA

Wang, Q., Wang, L., Zhang, L., Zhao, C., Liu, Y., Liu, L., Yuan, L., Feng, M., Wang, G., Li, L., Zhang, S., Yuan, Y., Kang, D., & Zhang, X. (2025). Characterizing ECOPD Phenotypes: Associations with In-Hospital Outcomes and Immunoinflammatory Mechanisms. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s505016

Vancouver

Wang Q, Wang L, Zhang L, Zhao C, Liu Y, Liu L, et al. Characterizing ECOPD Phenotypes: Associations with In-Hospital Outcomes and Immunoinflammatory Mechanisms. International Journal of Chronic Obstructive Pulmonary Disease. 2025. doi:10.2147/copd.s505016

BibTeX
@article{Wang2025,
  author = {Wang, Qin and Wang, Lei and Zhang, Li and Zhao, Chongyang and Liu, Ying and Liu, Lei and Yuan, Lishan and Feng, Min and Wang, Gang and Li, Li and Zhang, Shuwen and Yuan, Yulai and Kang, Deying and Zhang, Xin},
  title = {Characterizing ECOPD Phenotypes: Associations with In-Hospital Outcomes and Immunoinflammatory Mechanisms},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2025},
  doi = {10.2147/copd.s505016}
}
Start for free →